Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products

Introduces a new, simpler and more effective way in which to interpret pharmaceutical aerosol particle size data from orally inhaled products (OIPs) Outlines a comprehensive product lifecycle management strategy in terms of in vitro characterization of APSD It leads those working with CIs or CI data to adopt more efficient approaches in their practice Includes supplementary material: sn.pub/extras